Susann Matthes

Title: Susann Matthes: Innovator in Xanthine Derivatives

Introduction

Susann Matthes is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her work on xanthine derivatives. With a total of three patents to her name, her innovations are paving the way for new treatments in serotonin-related diseases.

Latest Patents

Her latest patents focus on xanthine derivatives and their use as medicaments. These inventions relate to a specific xanthine derivative defined by a chemical formula, or a salt thereof, which is particularly effective in treating serotonin-related diseases or disorders. The novel xanthine compounds developed by Matthes are capable of inhibiting tryptophan hydroxylases (TPH), enzymes involved in the biosynthesis of serotonin. This inhibition is crucial as it influences serotonin levels in the body, offering potential therapeutic benefits.

Career Highlights

Throughout her career, Susann Matthes has worked with esteemed organizations such as the Max Delbrück Center for Molecular Medicine and the Forschungsverbund Berlin e.V. Her research has been instrumental in advancing the understanding of serotonin-related conditions and developing effective pharmaceutical preparations.

Collaborations

Some of her notable coworkers include Michael Bader and Edgar Specker. Their collaborative efforts have contributed to the success of her research and innovations in the field.

Conclusion

Susann Matthes stands out as a key figure in the development of xanthine derivatives for medicinal use. Her work not only enhances our understanding of serotonin-related disorders but also opens new avenues for treatment.